Capital Analysts, LLC Amarin Corp Plcuk Transaction History

Capital Analysts, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$4.26 - $6.5 $2,747 - $4,192	-645 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$5.03 - $8.8 $3,244 - $5,676	645 New	645 $4,000
Q4 2020 Feb 16, 2021	SELL	$4.04 - $5.31 $848 - $1,115	-210 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$4.0 - $21.53 $240 - $1,291	60 Added 40.0%	210 $1,000
Q3 2019 Nov 12, 2019	BUY	$13.89 - $23.16 $555 - $926	40 Added 36.36%	150 $2,000
Q1 2019 May 13, 2019	BUY	$12.61 - $22.33 $252 - $446	20 Added 22.22%	110 $2,000
Q4 2018 Feb 13, 2019	BUY	$12.41 - $22.98 $1,116 - $2,068	90 New	90 $1,000

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $214M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Capital Analysts, LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Analysts, LLC with notifications on news.